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Abstract: The 2018 Nigerian Lassa fever season saw the largest ever recorded upsurge of 
cases, raising concerns over the emergence of a strain with increased transmission rate. To 
understand the molecular epidemiology of this upsurge we performed, for the first time at the 
epicenter of an unfolding outbreak, metagenomic nanopore sequencing directly from patient 5 
samples, an approach dictated by the highly variable genome of the target pathogen. Genomic 
data and phylogenetic reconstructions were communicated immediately to Nigerian 
authorities and the WHO to inform the public health response. Real-time analysis of 36 
genomes, and subsequent confirmation using all 120 samples sequenced in-country, revealed 
extensive diversity and phylogenetic intermingling with strains from previous years, 10 
suggesting independent zoonotic transmission events; allaying concerns of an emergent strain 
or extensive human-to-human transmission. 
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Main Text:  
Lassa fever is an acute viral hemorrhagic illness, first described in 1969 in the town of 
Lassa, Nigeria (1). It is contracted primarily through exposure to urine or feces of infected 
Mastomys spp. rodents or, less frequently, through the bodily fluids of infected humans. 
Lassa virus (LASV) is endemic in parts of West Africa including Nigeria, Benin, Côte 5 
d'Ivoire, Mali, Sierra Leone, Guinea and Liberia (2). The upsurge of Lassa Fever cases during 
the 2018 endemic season in Nigeria — referred to here as the 2018 Lassa fever outbreak — 
has been the largest on record reaching 1,495 suspected cases, 376 confirmed cases, and 
affecting over 18 states by March 18th (Fig. S1). This notably exceeds the 102 confirmed 
cases reported during the same period in 2017 (Fig. S1) (3). The unprecedented scale of the 10 
outbreak raised fears of the emergence of a strain with a higher rate of transmission. Due to 
these concerns, on February 28th the Nigeria Centre for Disease Control (NCDC) and the 
WHO urgently requested sequencing information and preliminary results from our pilot-scale 
study, which employed in-country, mid-outbreak, viral genome sequencing directly from 
clinical samples using a metagenomic approach on the Oxford Nanopore MinION device 15 
(Oxford Nanopore Technologies, UK). This instigated a major upscale in sequencing efforts, 
leading to sequencing of 120 samples.  
Nanopore sequencing is an emerging technology with significant potential. The 
MinION is a small and robust sequencing device suited for the genetic analysis of pathogens 
in remote or resource-limited settings (4). Nanopore sequencing of PCR-amplicons of Ebola 20 
virus genomes provided important data from the field in real-time during the 2014-2016 
Ebola virus disease outbreak in West Africa (5) and a more sophisticated multiplex amplicon 
sequencing methodology (6) has been used to great effect during recent Zika and Yellow 
fever outbreaks in Brazil (7, 8). However such an amplicon-based approach is extremely 
challenging for highly variable pathogens such as LASV. Due to an inter-strain nucleic acid 25 
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sequence variation of up to 32% and 25% for the L (large segment encoding the RNA 
polymerase and the zinc binding protein) and S (small segment encoding the glycoprotein 
and the nucleoprotein) segments respectively (9), even PCR-based laboratory diagnosis poses 
a significant challenge. Designing targeted whole-genome sequencing approaches, such as 
PCR amplicons or bait/capture probes, without prior knowledge of the targeted LASV 5 
lineage is therefore cumbersome. Random reverse-transcription and amplification by 
Sequence-Independent Single Primer Amplification (SISPA) for metagenomic sequencing to 
identify RNA viruses has been demonstrated to work on the MinION (10) and our previous 
work highlighted the feasibility of retrieving complete viral genomes directly from patient 
samples at clinically relevant viral titers using this approach for Dengue and Chikungunya 10 
viruses (11).  We describe here the application of field metagenomic sequencing of LASV at 
the Irrua Specialist Teaching Hospital (ISTH), Edo State, during the 2018 Lassa fever season.  
A total of 120 LASV positive samples were sequenced during a seven-week mission, 
selected based on Cycle threshold (Ct) value and location of the 341 cases reported by ISTH 
between 1st January and 18th March 2018 (Figs. S1 and S2). The majority of samples 15 
originated from Edo state followed by Ondo and Ebonyi (Fig. S2). Samples selected covered 
the wide range of clinical viral loads observed, including several samples testing negative in 
one of the two real-time RT-PCR assays used (Fig. S3 and Data S1). Up to six samples were 
run in multiplex per MinION flow cell, along with a negative control. To produce high-
confidence consensus sequences for phylogenetic inference we chose to map both basecalled 20 
reads and raw signal data to a reference sequence and call variants using Nanopolish 
software, as developed for the West African Ebola virus disease outbreak (5); basecalled 
reads were then remapped to the consensus and a further round of correction was applied 
(Fig. S4). Owing to the diversity of LASV, selection of an individual reference genome for 
read alignment was required for each sample. To select the closest existing LASV reference 25 
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genome, non-human reads from each sample were assembled de novo using Canu (12). A 
significant proportion of reads generated per sample were LASV at an average frequency of 
4.26% with a maximum of 42.9% allowing for sufficient genomic sequence (>70%) for 
phylogenetic comparison of at least one segment in 91 of the samples tested (Figs. S3-6).  
Additionally, sequences were validated by Illumina re-sequencing of 14 SISPA 5 
preparations which matched with their Nanopore counterpart with little to no divergence 
between them confirming the accuracy of the Nanopore approach (Table S1).  
Metagenomic classification using the Centrifuge software system (13) identified 
0.10% of reads from sample 110 as originating from Hepatitis A virus; providing 74% 
genome coverage at 20-fold depth. LASV accounted for 0.83% in the same sample, providing 10 
96% genome coverage. This demonstrates the potential of this simple approach to identify 
multiple RNA viruses, including those present as co-infections. In all other samples tested, 
LASV was the sole pathogen identified despite a small number reads classified as other 
viruses (Fig. S7 and Data S1).  
To dissect the molecular epidemiology of the 2018 Lassa fever outbreak in Nigeria, 15 
we performed phylogenetic analysis of all newly generated LASV sequences together with 
unpublished sequences from previous years (Data S2) and sequences available in GenBank. 
We use this as a frame of reference to document how the genomic data generated in real-time 
(made publicly available as posted on virological.org) provided valuable epidemiological 
insights into the unfolding outbreak dynamics.  20 
Maximum likelihood phylogenetic reconstruction of the S segment sequences 
indicates that all 2018 viruses fall within the Nigerian LASV diversity, specifically within 
genotype II and III, and they are phylogenetically interspersed with Nigerian LASV 
sequences from previous years (Fig. 1). This phylogenetic pattern is mimicked by the L 
segment reconstruction (Fig. S8). Only seven viruses in the entire complete genome data set 25 
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(n = 348) were identified as clustering significantly differently in the L and S segment 
(Supplementary Methods), in line with the small number of potential LASV reassortments 
identified previously (9). The phylogenetic pattern clearly implicates independent spill-over 
from rodent hosts as the major driver of Lassa fever incidence during the outbreak (Figs. 1 
and S8). 5 
However, a number of sequences from the 2018 outbreak clustered as pairs in the 
phylogenetic reconstructions, raising concerns over human-to-human transmissions. We 
illustrate such cluster pairs in a Bayesian time-measured tree estimated from genotype II S 
(Fig. 2) and L segment sequences (Fig. S9). These analyses resulted in highly similar 
evolutionary rate estimates for both segments (mean around 1.2x10-3 subst./site/year, Figs. 2 10 
and S9-S10), in agreement with previous estimates (9). We used these rate estimates together 
with an estimate of the time between successive cases in a transmission chain to assess how 
many substitutions can be expected between directly linked infections. We compare 
conservative to more liberal expectations, the latter accommodating an independent upper 
estimate of potential sequencing errors (Figs. 2 and S9). In the S segment, for example, more 15 
than 2 substitutions between sequences from directly linked infections is highly unlikely 
(P<0.01 and P=0.03 respectively for the conservative and liberal probability estimates). This 
expectation is consistent with the low number of substitutions observed in the coding region 
of human-to-human LASV transmission (14). Four clusters of sequences showing ≤4 and ≤12 
nucleotide differences in S and L segment, respectively, were identified (035-045, 035-058, 20 
137-138, and 053-089-106; for some of them only S or L segment sequence was available). 
Retrospective tracing revealed that the sequences for pairs 137-138 and 035-058, 
respectively, were in fact derived from the same patients. Epidemiological investigation of 
the remaining clusters did not provide evidence for transmission chains, though direct linkage 
cannot be excluded. In conclusion, even when applying liberal assumptions for the number of 25 
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mutations during human-to-human transmission, the vast majority of cases during the 2018 
outbreak resulted from spill-over from the natural reservoir.  
 A request for information on circulating strains was made on 28th February at the 
height of the outbreak, within 10 days our pilot research study was expedited, and the initial 
analysis completed. The fact that the 2018 outbreak was fueled by the circulating LASV 5 
diversity and not by transmission of a new or divergent lineage was already evident from the 
first seven genomes generated by 10th March (Fig. S1). This information was promptly 
communicated to the NCDC forming the basis of their report “Early Results of Lassa Virus 
Sequencing & Implications for Current Outbreak Response in Nigeria” released on March 
12th 2018 (15). While this small sample was restricted to genotype II, the final collection of 10 
36 LASV genome sequences generated on-site also included a representative of genotype III 
(Figs. 1 and S9), further supporting the spill-over of longstanding LASV diversity in the 
outbreak. The conclusions drawn from the first set of genome sequences immediately 
removed fears of extensive human-to-human transmission and allowed public health 
resources to be allocated appropriately. The response was focused on intensified community 15 
engagement on rodent control, environmental sanitation, and safe food storage. Further 
research is needed to evaluate if improved diagnostics and disease awareness and/or 
ecological and climate factors promoting transmission are the drivers behind the changing 
epidemiology of Lassa fever in Nigeria. 
Portable metagenomic sequencing of genetically diverse RNA viruses on the 20 
MinION, direct from patient samples without the need to export material outside of the 
country of origin and with no pathogen-specific enrichment, is shown to be a feasible 
methodology enabling a real-time characterization of potential outbreaks in the field.  
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LEGENDS TO FIGURES 5 
Figure 1. Phylogenetic reconstruction of the S segment data. The circular tree includes 96 
sequences from 2012 to 2017, 88 sequences from 2018 and sequences available from 
GenBank. The rectangular tree focuses on the genotype II clade (in blue in the circular tree) 
that includes most of the 2018 sequences. The six genotypes are indicated with different 
colors and roman symbols. Bootstrap support >90% is indicated with a small grey circle at 10 
the middle of their respective branches. The color strip highlights the human LASV 
sequences obtained from previous years (light grey), sequences obtained from rodent samples 
(dark grey) and 2018 sequences as light pink for the first seven sequences generated in 
Nigeria, magenta for the remaining 28 sequences analysed on-site, and purple for the 
remaining finalised in Europe. The same color code is used in the genotype II rectangular 15 
tree. Bootstrap values >80% are shown for the major genotype II lineages. 
 
Figure 2. Assessing the potential for direct linkage between pairs of 2018 sequences in 
the S segment. The maximum clade credibility tree summarizes a Bayesian evolutionary 
inference for the genotype II sequences in the S segment. A time scale and a marginal 20 
posterior distribution for the time to the most recent common ancestor are shown to the left. 
The size of the internal node circles reflects posterior probability support values. 2018 
sequences clustering as pairs are indicated in purple; the number of substitutions between 
them is indicated at their respective tips. A posterior estimate of the evolutionary rate and 
probability distributions for observing a given number of substitutions during a human-to-25 
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human transmission event are shown as insets. The distribution represented by grey bars is 
based on the mean evolutionary rate estimate and a mean estimate for the generation time 
whereas the light blue distribution is based on upper estimates and also incorporates an upper 
estimate for the MinION sequencing error (Supplementary Methods). At the bottom, clusters 
of sequences for which human-to-human transmission cannot be excluded according to the 5 
upper estimates of generation time are indicated. A pair of identical sequences (137-138) that 
was retrospectively found to be derived from the same patient is marked with a grey box. One 
pair (096-115) was still disregarded as potential transmission chain due to 21 differences in L 
segment (Fig. S9). The temporal signal prior to BEAST inference was explored in Fig. S10. 
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Materials and Methods 
 
Sample collection 
 
Samples from suspected Lassa fever patients were routinely tested for presence of Lassa 5 
virus (LASV) RNA at the Institute of Lassa Fever Research and Control (ILFRC) at Irrua 
Specialist Teaching Hospital (ISTH), Irrua, Edo State, Nigeria, using two real-time reverse 
transcription PCR (RT-PCR) assays, the commercially available Altona kit (RealStar® Lassa 
Virus RT-PCR Kit 1.0 CE, Altona Diagnostics, Hamburg, Germany) targeting the S segment along 
with an in-house version of the previously described Nikisins RT-PCR targeting the L segment 10 
(16). The latter has been optimized by using the SuperScript™ III Platinum™ One-Step qRT-PCR 
reagents (Invitrogen) according to manufacturer instructions (without magnesium sulfate; reaction 
volume of 25 µl). The temperature profile was identical to that of the Altona assay, while primer 
and probe sequences and concentrations were used as described (16). Both Altona and Nikisins 
real-time RT-PCR assays have been implemented and extensively evaluated in terms of analytical 15 
and clinical characteristics by the authors, and were found to have good performance in diagnosing 
acute Lassa fever when used in combination (unpublished data). Therefore, all samples were 
generally tested in both assays, although the Ct values obtained with the two assays may differ 
(Fig. S3). A total of 120 plasma, breast milk, or cerebrospinal fluid samples identified as LASV-
positive by one or both real-time PCRs were selected for direct sequencing based on Ct value 20 
(inversely correlated with viral load) and/or geographical information on the sample origin. The 
use of diagnostic leftover specimen and corresponding patient data was approved by the ISTH 
Research and Ethics Committee (approval ISTH/HREC/20171208/45). 
 
Nucleic acid extraction and metagenomic library preparation 25 
 
Extraction and metagenomic library preparation were performed as described in detail 
previously (11). Briefly, 70 µl of each sample was manually extracted using the QIAamp viral 
RNA kit (Qiagen); nucleic acid extracts were then subjected to a DNAse digest (TURBO DNase, 
Thermo Fisher Scientific), randomly reverse-transcribed, and amplified using a Sequence 30 
Independent Single Primer Amplification (SISPA) approach. 
  
MinION library preparation and sequencing 
 
Barcoded MinION sequencing libraries were prepared using the Ligation Sequencing kit 
1D (SQK-LSK108) and Native Barcoding Kit (EXP-NBD103) (Oxford Nanopore Technologies 5 
[ONT]). Up to 6 samples plus one negative control, consisting of a water blank sample included 
in each batch of extractions, were included per multiplex library. Libraries were sequenced for 48 
h on FLO-MIN106 flow cells using a Mark 1B MinION device (Oxford Nanopore Technologies).  
 
Data handling 10 
 
An overview of the data analysis workflow used can be found in Fig. S4. Raw reads were 
basecalled using the ONT Albacore sequencing pipeline software v2.2.7, and output basecalled 
fastq files were concatenated and demultiplexed using Porechop v0.2.3 
(https://github.com/rrwick/Porechop). SeqTK (https://github.com/lh3/seqtk) was then used to trim 15 
30 bp from both ends to eliminate primer sequences and resulting fastq files were mapped to the 
human genome (human_g1k_v37; 1000 genomes). Mapped reads were excluded from the 
subsequent de novo assembly, which allowed for LASV reference identification. CANU v1.6 (12) 
was used for de novo assembly with the following settings: corOutCoverage=1000, 
genomeSize=10000, minReadLength=400, minOverlapLength=200. Canu genomeSize and 20 
minReadLength parameters were lowered for samples that did not assemble any LASV contigs 
with the specified values. Assemblies were then used in a blastn search against the NCBI database 
to identify the closest LASV reference genome available. BWA MEM v0.7.15 (17) using -x ont2d 
mode allowed for read alignment to the reference genome identified (see supplementary data file 
S1 for references used for each sample). Nanopolish (v0.9.0) variants (5, 18) using --snps mode 25 
was used to detect single-nucleotide polymorphisms (SNPs) with respect to the reference genome 
and Nanopolish output vcf file was used as input to the margin_cons.py script (6) 
(https://github.com/zibraproject/zika-pipeline) to filter out low-quality or low-coverage candidate 
SNPs and compute a consensus. Reads were then re-aligned to the consensus and a second round 
of correction performed with consensus bases called at a minimum support fraction of 70%.  30 
Samtools v1.7 was used to compute percentage reads mapped along with coverage depth 
and Bedtools v2.27.1 was used to calculate genome coverage at 20×. Taxonomic classification of 
the data was performed using Centrifuge v1.0.4 (13) and the provided “Bacteria, Archaea, Viruses, 
Human (compressed)” indexes (update version 12/06/2016). 
 5 
 
Illumina library preparation, sequencing, and analysis 
 
Nextera XT v2 Kit (Illumina) sequencing libraries were prepared using 1 ng of SISPA-
amplified cDNA, according to the manufacturer's instructions, with a total of 14 cycles in the 10 
library amplification PCR. Samples were multiplexed in batches of maximum 12 per run and 
sequenced on a 2 × 300 bp Illumina MiSeq run. BWA MEM v0.7.15 (17) was used with default 
settings to align reads to the references. Mapping consensus sequences for Illumina were 
generated using QuasiBam (19).  
 15 
Data set compilation, alignment, and reassortment/recombination analyses 
 
The sequence data sets were assembled by combining the newly generated MinION 
sequences plus Illumina controls from 2018 (NCBI Bioproject PRJNA482058), new sequences 
generated from 2012-2017 LASV isolates (PRJNA482054 and PRJNA482058; D. U. Ehichioya, 20 
unpublished), and LASV genomic sequences available on GenBank. Only sequences with less 
than 30% missing bases per segment were included, which resulted in a total of 352 sequences 
for the L segment (79 MinION sequences from 2018 and 14 Illumina controls, and 64 new 
sequences from previous years) and 425 sequences for the S segment (88 MinION sequences 
from 2018 and 14 Illumina controls, and 96 new sequences from previous years).  25 
The L and S segment alignments were compiled separately by concatenating the Z and L 
(polymerase) gene sequences and the glycoprotein and nucleoprotein gene sequences, 
respectively, and aligning them using Muscle (20). Ambiguously aligned regions in the 
polymerase gene of the L segment were removed. Potential segment reassortment and 
phylogenetic inconsistency within each segment was examined using RDP4 (21) based on a 30 
significant result for more than three of the following recombination detection methods: RDP, 
GENECONV, Chimaera, MaxChi, Bootscan, SiScan, and 3Seq. We used a 0.05 as highest 
acceptable P-value for each method and a Bonferroni correction for multiple testing. Among the 
strains for which both an L and S segment sequence was available, this analysis revealed 7 
potential reassortants (5 among previously obtained genomes and two new ones). Relative short 
phylogenetically inconsistent stretches in the L (n = 3) and S (n = 1) segment sequences identified 5 
using the same procedure were masked as unobserved characters (‘N’) prior to phylogenetic 
analyses and BEAST inference. 
 
Maximum likelihood phylogenetic reconstruction and Bayesian time-measured phylogenetic 
inference. 10 
 
We used RAxML (22) to infer maximum likelihood (ML) phylogenetic trees under a 
general time-reversible (GTR) substitution model with gamma-distributed among-site rate 
heterogeneity. Upon evaluating node support using 1000 bootstrap replicates, we employed a 
thorough tree search using relatively exhaustive subtree pruning and regrafting (SPR) moves to 15 
search for the ML tree. 
We used plots of root-to-tip divergence as a function of sampling time summarized by 
TempEst (23) from the ML trees to examine the temporal signal in the genotype II L & S data 
sets (prior to fitting a dated tip model in subsequent Bayesian analyses). This revealed that the 
pattern of divergence accumulation over the sampling time range was obfuscated by rate variation 20 
between the relatively divergent sub-clusters within genotype II for the S segment (Fig. S10), as 
was previously observed in different viral example with a similar time to the most recent common 
ancestor (24). Focusing on the major sub-cluster in this genotype however (n = 202, 85%), allows 
identifying a reasonable temporal signal (Fig. S10). The rate variability along deep branches 
appears to be less pronounced in the L segment, but in this case, there is considerably more root-25 
to-tip divergence variability for the 2018 genotype II sequences (both in the complete genotype 
II data set and the major sub-cluster, Fig. S10). 
Bayesian time-measured evolutionary histories were reconstructed for the genotype II 
sequences using BEAST v1.10 (25). Specifically, we estimated a posterior distribution of time-
measured trees for the genotype II S segment data set. Identical sequences from previous years 30 
were reduced to a single representative sequence. We specified six partitions, one for each codon 
position in both the glycoprotein and nucleoprotein genes (constraining relative substitution rates 
to sum to 3 separately in both genes) and a separate GTR model of substitution with gamma 
distributed rate variation among sites for each partition, but with hierarchical prior distributions 
over the different GTR substitution rates to share information across partitions (26). We used a 
flexible Bayesian skyride tree prior (27) and an uncorrelated lognormal relaxed molecular clock 5 
model to allow for rate variation among lineages (28). When exact sampling dates were not 
available, tip ages were integrated over their appropriate uncertainty (month or year). In addition 
to standard Markov-chain Monte Carlo (MCMC) transition kernel, we employed an adaptive 
multivariate normal kernel on the substitution model parameters (29). Multiple independent 
MCMC chains were run until the continuous parameters in the combined posterior sample 10 
achieved sufficiently high effective sample sizes (ESSs >100). We summarized continuous 
parameters using mean estimates and 95% highest posterior density (HPD) intervals. Trees were 
summarized as a maximum clade credibility (MCC) trees using TreeAnnotator. Alignments, ML 
trees, BEAST xml files, and MCC trees are available at: https://github.com/ISTH-BNITM-
PHE/LASVsequencing. 15 
 
Assessing the potential for direct linkage among the 2018 samples 
 
To investigate whether pairs of 2018 sequences could represent directly linked infections 
(human-to-human transmission), we calculated the Poisson probability distribution to observe a 20 
number of substitutions conditioning on (i) the BEAST estimate of the mean nucleotide 
substitution rate and (ii) an estimate of the Lassa fever generation time (~ the time between 
successive cases in a transmission chain). For the latter, we used three weeks based on a mean 
estimate of 10 days for the incubation period and a mean time to hospital presentation after disease 
onset of 8 to 10 days. So, we obtain the rate parameter (λ1) for the Poisson probability distribution 25 
by dividing the substitution rate (per genome segment per time unit) by the generation time in the 
same time units. 
We also calculated a second version of this probability distribution taking caution not to 
reject direct linkage for large numbers of substitutions. To this purpose, we calculated a Poisson 
rate parameter (λ2) based on the 95% upper HPD interval estimate for the rate of evolution and a 30 
longer generation time of 4 weeks. In addition, we incorporated a liberal estimate of the basecalling 
differences observed between the subset of MinION sequences and the corresponding Illumina 
controls by fitting a Poisson distribution to the substitutions to estimate the sequencing error rate 
(λe). For the second more liberal version of the Poisson probability distribution we thus take as rate 
the sum of the per-generation substitution rate parameter (λ2) and twice the sequencing error (λe) 
because we model differences between two sequences generated using MinION sequencing. 5 
  
 Fig. S1. Epidemiology of the Lassa fever outbreak and timeline of sequencing in Nigeria.  
(A) Epidemiological curve for 2018. ISTH confirmed 341 of the 376 Lassa fever cases reported 
by Nigeria Center of Disease Control (NCDC) between 1st January and 18th March 2018. The 
epidemiological curve shows the 341 confirmed cases according to patient outcome. (B) Number 5 
of cases diagnosed and reported by ISTH from 2015 through 2018. (C) Number of samples 
sequenced per epidemiological week in 2018. (D) Timeline of sequencing efforts. Equipment 
and consumables for sequencing of ~50 samples and the computer hardware were deployed at 
ISTH with the aim of testing and troubleshooting on-site sequencing capacity. Sequencing data 
were requested by the NCDC on the 28th of February. The alarming increase in cases effectuated 10 
an upscale in efforts leading to sequencing of 120 samples on-site.  
  
 Fig. S2. Annotated map of confirmed Lassa fever cases between 1st January and 18th March 
2018.  
(A) Affected States; (B-C) geographical origin of patients from whom samples were sequenced 
(orange markers).  5 
 
  
 
 
Fig. S3. Correlation between Ct values from Altona and Nikisins real-time RT-PCR assays.  
Seven samples tested negative in the Nikisins assay and one tested negative in the Altona assay, 
demonstrating the importance of combined use of both assays for diagnosis of acute Lassa fever 5 
and subsequent sequencing. Negative results have been assigned a Ct value of 45 to facilitate 
visualization. Values of samples from survivors are plotted in grey, and those from deceased 
patients in black. 
  
 Fig. S4. Workflow of consensus sequence generation.  
Summary of the steps performed during the bioinformatics pipeline for consensus generation. 
   
 Fig. S5. Percentage of reads mapping to LASV depending on Ct value in Altona and 
Nikisins real-time RT-PCR assay.  
Negative results have been assigned a Ct value of 45 to facilitate visualization. Values of 
samples from survivors are plotted in grey and those from deceased patients in black. 5 
  
 Fig. S6. Percentage of genome coverage (20×) per segment depending on Ct value in Altona 
and Nikisins real-time RT-PCR assay.  
Negative results have been assigned a Ct value of 45 to facilitate visualization. Values of 
samples from survivors are plotted in grey and those from deceased patients in black. 5 
  
 Fig. S7. Classification of MinION reads depending on Ct value in (A) Altona and (B) Nikisins real-time RT-PCR assay. 
Reads were classified by Centrifuge software as either Arenaviridae or other viruses. The analysis allowed for identification of a co-
infection in sample 110 with 0.1% reads classifying as Hepatitis A virus. In all other samples, the distribution of reads classified 
within the other viruses did not include a sufficient proportion of specific origin to suggest the presence of a virus other than LASV. 5 
na, not applicable as samples were not tested with the respective RT-PCR.  
 
 
Fig. S8. Phylogenetic reconstruction of the L segment data.  
The circular tree includes 64 new sequences from 2012 to 2017 (PRJNA482054 and 
PRJNA482058), 79 new sequences from 2018 (PRJNA482058), and sequences available from 5 
GenBank. The rectangular tree focuses on the genotype II clade (in blue in the circular tree) that 
includes most of the 2018 sequences. In the circular tree, the 6 genotypes are indicated with 
different colors and roman symbols. Bootstrap support >90% is indicated with a small grey circle 
at the middle of their respective branches. The color strip highlights the human LASV sequences 
obtained from previous years (light grey), sequences obtained from rodent samples (dark grey) 10 
and 2018 sequences (pink/magenta/purple). The first 7 sequences generated and analyzed in 
Nigeria are represented by a light pink color. The additional 28 sequences that were analyzed on-
site are marked with a magenta color. All other 2018 sequences analyzed upon return to Europe 
are marked in purple. The same color code is used in the genotype II rectangular tree. Bootstrap 
values >80% are shown for the major lineages. 15 
  
 Fig. S9. Assessing the potential for direct linkage between pairs of 2018 sequences in the L 
segment.  
The maximum clade credibility tree summarizes a Bayesian evolutionary inference for the 
genotype II sequences in the L segment. A time scale and a marginal posterior distribution for 5 
the time to the most recent common ancestor are shown to the left. The size of the internal node 
circles reflects posterior probability support values. Sequences clustering as pairs are indicated in 
purple; the number of substitutions between them is indicated at their respective tips. A summary 
for the posterior estimate of the evolutionary rate as well as the probability distributions for 
observing a number of substitutions for directly linked infections are shown as inset. The 10 
distribution represented by grey bars is based on the mean evolutionary rate estimate and a mean 
estimate for the generation time whereas the light blue distribution is based on upper estimates 
and also incorporates an upper estimate for the MinION sequencing error (Supplementary 
Methods). At the bottom, a pair of sequences (035/058) that was retrospectively found to be 
derived from the same patient is marked with a grey box. For one pair of sequences with four 15 
substitutions (053-106), a link cannot be excluded. One pair (096-115), for which direct linkage 
could not be excluded based on the S segment data with 2 nucleotide differences (Fig. 2), was 
disregarded as potential transmission chain due to 21 differences in L segment. The temporal 
signal was explored prior to BEAST inference (Fig. S10). 
  20 
 Fig. S10. Root-to-tip divergence of LASV genotype II sequences as a function of sampling 
time for the S (A-B) and L (C-D) segments.  
The temporal signal was explored prior to the BEAST inference using regression analysis, i.e. 
root-to-tip divergence as a function of sampling time. (A) Complete genotype II data set (n = 5 
238) and (B) Major subclade (n = 202, 85%) of the S segment. (C) Complete genotype II data set 
(n = 206) and (D) Major subclade (n = 176, 85%) of the L segment.  
  
Sample 
ID 
Segment 
Length 
Total 
Disagreements 
In 
coding 
regions 
Positions (Illumina > Nanopore, non-coding/coding) 
S segment 
001 3490 0 0 
 
013 3367 0 0 
 
014 3407 1 0 1587T>G 
021 3385 0 0 
 
036 3387 0 0 
 
066 3393 0 0 
 
072 3398 6 0 1554C>G, 1568C>G, 1569G>A, 1570C>A,1572G>A, 1573A>G 
073 3406 1 0 3422C>G 
074 3367 0 0 
 
075 3412 0 0 
 
115 3387 0 0 
 
119 3403 2 2 596C>A, 597A>C 
126 3407 1 0 2C>G 
131 3389 0 0 
 
L segment 
001 7196 2 0 2A>T, 416T>G 
013 7230 0 0 
 
014 7245 1 0 445G>A 
021 7237 0 0 
 
036 7261 1 0 7209T>C 
066 7135 1 1 274G>T 
072 7250 0 0 
 
073 7260 4 3 5792G>T, 5793A>G, 5795G>A, C>T7258. 
074 7238 0 0 
 
075 7256 0 0 
 
115 7183 3 3 727C>T, 728T>C, 731C>T 
119 7258 2 0 404C>T, 407C>T 
126 7245 0 0 
 
131 7238 0 0 
 
 
Table S1. Comparison between Nanopore and Illumina consensus sequences. 
A total of 14 samples were randomly selected for re-sequencing using Illumina technology. 
Nucleotide disagreements between the Illumina and Nanopore derived sequences are listed for 
each segment. Disagreements within the coding regions, which were used in phylogenetic 5 
analysis, are highlighted in red. Ten of 14 had zero differences in either S or L segment coding 
regions, whilst four had 1-3 nucleotide disagreements in total across the combined S and L 
coding regions. Visual inspection of these regions suggested the basecall was consistent with the 
read alignment for both the Illumina and Nanopore data and so do not appear to be the result of 
the extra “noise” within the Nanopore signal.  10 
  
Captions Supplementary Data S1 and S2 
 
Data S1. Metadata of the 120 samples sequenced. 
 
Data S2. Identifiers and Bioproject numbers of the 2012 to 2017 LASV sequences. 5 
